Venture Capital

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

November 21, 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

November 20, 2024

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

THIS WEEK'S STORIES

Kevin Krause named President and CEO of ArrePath

November 19, 2024

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors

November 22, 2024

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

November 20, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

Ferment Launches $20M Studio Fund to Accelerate Biotech Solutions Across Vital Industries

ChapsVision Strengthens AI Capabilities With Sinequa Acquisition and Completes New US$90M Funding Round

Most Read

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure

HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500

Inspira Health Announces Promotion of Julie H. Ellis, MBA, SHRM-SCP to Senior Vice President and Chief Human Resources Officer

EDITOR PICKS

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

THIS WEEK'S STORIES

Kevin Krause named President and CEO of ArrePath

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

POPULAR CATEGORY

ABOUT US

FOLLOW US